Interra Health Named Digital Health Awards Quarterfinalist
The company was recognized for its innovation in medication access and prescription pricing transparency.
Updated on Sept. 28, 2026 in Healthcare
Live Poll
Do you believe digital health tools effectively help you manage your medication adherence?
Interra Health has been selected as a quarterfinalist in the 2026 Digital Health & AI Awards within the therapeutics and pharmacy category. The organization received this recognition for its Patient Connect platform, which streamlines medication access at the point of care.
Why it matters
Improving medication adherence is a critical challenge in the United States, where more than half of prescriptions for chronic conditions are not taken as directed. This non-adherence leads to an estimated $300 billion in avoidable healthcare costs annually.
The Digital Health Hub Foundation manages an ecosystem of over 30,000 members while monitoring the $300 billion in annual costs tied to medication non-adherence. Finalists for the current awards cycle have yet to be determined.
The players
Interra Health
This company provides digital platforms focused on medication access and transparency at the point of care.
Digital Health Hub Foundation
This San Francisco-based organization oversees an ecosystem of 30,000 members and hosts the annual Digital Health & AI Awards.
The details
The Patient Connect platform integrates prescription pricing, coverage, and access insights by utilizing technology from partners like DoseSpot, Arrive Health, and pVerify. Judges from the technology, investment, and clinical sectors evaluate candidates based on their potential to drive systemic improvement.
Timeline
September 28, 2026: Interra Health was named a quarterfinalist.
October 12, 2026: Organizers will announce the competition finalists.
November 16, 2026: The awards program will host its Grand Finale in Las Vegas.
Market Landscape
Interra Health joins a cohort of innovators vetted by the Digital Health & AI Awards, a program that highlights significant shifts in healthcare technology adoption. This recognition underscores a broader industry move toward integrating price transparency tools directly into clinical workflows to capture market share.
Consumers struggling with prescription costs may see increased access to pricing transparency through the expansion of platforms like Patient Connect. As these tools become more common, patients might find it easier to identify affordable medication options at the point of care.
The takeaway
Focusing on prescription transparency is a practical strategy to address the significant financial burden caused by medication non-adherence. As these technologies scale, the integration of price and access data remains a vital development for patients managing chronic conditions.
What happens next
Finalists for the 2026 Digital Health & AI Awards will be announced on October 12, 2026, followed by the Grand Finale event at HLTH on November 16, 2026.
Further reading
Learn more about the latest innovations in the Healthcare sector.
More information
For more information on the company's platform, visit the Interra Health website.
Live Poll
Do you believe digital health tools effectively help you manage your medication adherence?
